Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genzyme Executive VP-Legal And Corporate Development Peter Wirth: An Interview With “The Pink Sheet” DAILY (Part 3 of 3)

Jun 13 2007

• By Shirley Haley

Related Content

Genzyme Executive VP-Legal And Corporate Development Peter Wirth: An Interview With “The Pink Sheet” DAILY (Part 2 of 3)

Jun 11 2007

Genzyme Executive VP-Legal And Corporate Development Peter Wirth: An Interview With “The Pink Sheet” DAILY (Part 1 of 3)

Jun 08 2007

Genzyme Campath MS Launch Could Be Delayed Two Years

May 02 2007

Genzyme Tolevamer Represents New Market Opportunity

Feb 14 2007

Genzyme Wins AnorMED As Millennium Backs Out Of Bidding War

Oct 18 2006

Genzyme Will Look To Differentiate Renvela With Improved Dosing

Dec 21 2006

Myozyme Is First FDA-Approved Inherited Muscle Disorder Therapy

May 01 2006

Genzyme Synvisc OA Therapy Boosts Margins, Holds Promise For New Claims

Mar 01 2005

Genzyme Eyeing Fourth Quarter Close For Ilex Merger

Oct 20 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window